115 related articles for article (PubMed ID: 37753773)
1. Monocyte related haematological indices in acute exacerbations of COPD - a new biomarker?
Dukić V; Muršić D; Popović Grle S; Jakopović M; Ružić A; Vukić Dugac A
Monaldi Arch Chest Dis; 2023 Sep; ():. PubMed ID: 37753773
[TBL] [Abstract][Full Text] [Related]
2. Platelet indices in stable chronic obstructive pulmonary disease - association with inflammatory markers, comorbidities and therapy.
Hlapčić I; Somborac-Bačura A; Popović-Grle S; Vukić Dugac A; Rogić D; Rako I; Žanić Grubišić T; Rumora L
Biochem Med (Zagreb); 2020 Feb; 30(1):010701. PubMed ID: 31839721
[TBL] [Abstract][Full Text] [Related]
3. Statin Use and the Risk of Subsequent Hospitalized Exacerbations in COPD Patients with Frequent Exacerbations.
Lin CM; Yang TM; Yang YH; Tsai YH; Lee CP; Chen PC; Chen WC; Hsieh MJ
Int J Chron Obstruct Pulmon Dis; 2020; 15():289-299. PubMed ID: 32103928
[TBL] [Abstract][Full Text] [Related]
4. Clinical Outcomes and Inflammatory Responses of the Frequent Exacerbator in Pulmonary Rehabilitation: A Prospective Cohort Study.
Jenkins AR; Holden NS; Gibbons LP; Jones AW
COPD; 2020 Jun; 17(3):253-260. PubMed ID: 32362176
[TBL] [Abstract][Full Text] [Related]
5. Analysis of sputum microbial metagenome in COPD based on exacerbation frequency and lung function: a case control study.
Li W; Wang B; Tan M; Song X; Xie S; Wang C
Respir Res; 2022 Nov; 23(1):321. PubMed ID: 36403054
[TBL] [Abstract][Full Text] [Related]
6. Stability of the frequent COPD exacerbator in the general population: A Danish nationwide register-based study.
Reilev M; Lykkegaard J; Halling A; Vestbo J; Søndergaard J; Pottegård A
NPJ Prim Care Respir Med; 2017 Apr; 27(1):25. PubMed ID: 28416794
[TBL] [Abstract][Full Text] [Related]
7. Increased mortality associated with frequent exacerbations in COPD patients with mild-to-moderate lung function impairment, and smokers with normal spirometry.
Fortis S; Wan ES; Kunisaki K; Eyck PT; Ballas ZK; Bowler RP; Crapo JD; Hokanson JE; Wendt C; Silverman EK; Comellas AP
Respir Med X; 2021 Nov; 3():. PubMed ID: 35911870
[TBL] [Abstract][Full Text] [Related]
8. Alterations of the neutrophil-lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients.
Taylan M; Demir M; Kaya H; Selimoglu Sen H; Abakay O; Carkanat Aİ; Abakay A; Tanrikulu AC; Sezgi C
Clin Respir J; 2017 May; 11(3):311-317. PubMed ID: 26096858
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil-to-Lymphocyte Ratio Predicts Clinical Outcome of Severe Acute Exacerbation of COPD in Frequent Exacerbators.
Lu FY; Chen R; Li N; Sun XW; Zhou M; Li QY; Guo Y
Int J Chron Obstruct Pulmon Dis; 2021; 16():341-349. PubMed ID: 33633446
[TBL] [Abstract][Full Text] [Related]
10. Impaired Blood Neutrophil Function in the Frequent Exacerbator of Chronic Obstructive Pulmonary Disease: A Proof-of-Concept Study.
Jones AW; Robinson R; Mohamed P; Davison G; Izzat HJ; Lewis KE
Lung; 2016 Dec; 194(6):881-887. PubMed ID: 27530251
[TBL] [Abstract][Full Text] [Related]
11. Serum CCL-18 level is a risk factor for COPD exacerbations requiring hospitalization.
Dilektasli AG; Demirdogen Cetinoglu E; Uzaslan E; Budak F; Coskun F; Ursavas A; Ercan I; Ege E
Int J Chron Obstruct Pulmon Dis; 2017; 12():199-208. PubMed ID: 28115842
[TBL] [Abstract][Full Text] [Related]
12. Short-Term Impact of the Frequency of COPD Exacerbations on Quality of Life.
Camac ER; Stumpf NA; Voelker HK; Criner GJ
Chronic Obstr Pulm Dis; 2022 Jul; 9(3):298-308. PubMed ID: 35397199
[TBL] [Abstract][Full Text] [Related]
13. Association Between Routine Blood Biomarkers and Clinical Phenotypes and Exacerbations in Chronic Obstructive Pulmonary Disease.
Nuñez A; Marras V; Harlander M; Mekov E; Esquinas C; Turel M; Lestan D; Petkov R; Yanev N; Pirina P; Negri S; Miravitlles M; Barrecheguren M
Int J Chron Obstruct Pulmon Dis; 2020; 15():681-690. PubMed ID: 32280207
[TBL] [Abstract][Full Text] [Related]
14. Identification of proteomic signatures associated with COPD frequent exacerbators.
Sun P; Ye R; Wang C; Bai S; Zhao L
Life Sci; 2019 Aug; 230():1-9. PubMed ID: 31121174
[TBL] [Abstract][Full Text] [Related]
15. CODEXS: A New Multidimensional Index to Better Predict Frequent COPD Exacerbators with Inclusion of Depression Score.
Deng D; Zhou A; Chen P; Shuang Q
Int J Chron Obstruct Pulmon Dis; 2020; 15():249-259. PubMed ID: 32099350
[TBL] [Abstract][Full Text] [Related]
16. "Frequent exacerbator" is a phenotype of poor prognosis in Japanese patients with chronic obstructive pulmonary disease.
Tomioka R; Kawayama T; Suetomo M; Kinoshita T; Tokunaga Y; Imaoka H; Matsunaga K; Okamoto M; Hoshino T
Int J Chron Obstruct Pulmon Dis; 2016; 11():207-16. PubMed ID: 26893552
[TBL] [Abstract][Full Text] [Related]
17. The relationship between oral health and COPD exacerbations.
Baldomero AK; Siddiqui M; Lo CY; Petersen A; Pragman AA; Connett JE; Kunisaki KM; Wendt CH
Int J Chron Obstruct Pulmon Dis; 2019; 14():881-892. PubMed ID: 31114185
[No Abstract] [Full Text] [Related]
18. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
[TBL] [Abstract][Full Text] [Related]
19. Influence of disease severity, smoking status and therapy regimes on leukocyte subsets and their ratios in stable chronic obstructive pulmonary disease.
Hlapčić I; Dugac AV; Popović-Grle S; Markelić I; Rako I; Rogić D; Rumora L
Arch Med Sci; 2022; 18(3):672-681. PubMed ID: 35591846
[TBL] [Abstract][Full Text] [Related]
20. The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia.
Duman D; Aksoy E; Agca MC; Kocak ND; Ozmen I; Akturk UA; Gungor S; Tepetam FM; Eroglu SA; Oztas S; Karakurt Z
Int J Chron Obstruct Pulmon Dis; 2015; 10():2469-78. PubMed ID: 26648709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
